Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Moxifloxacin (Avelox) is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 41.00 | |
200 mg | In stock | $ 58.00 | |
500 mg | In stock | $ 88.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Moxifloxacin (Avelox) is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae. |
Synonyms | Avelox, Moxeza |
Molecular Weight | 401.43 |
Formula | C21H24FN3O4 |
CAS No. | 151096-09-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (236.65 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Moxifloxacin 151096-09-2 Microbiology/Virology Others Antibiotic Antibacterial Avelox inhibit Moxeza Bacterial Inhibitor inhibitor